Hit enter to search or ESC to close
Chembio Diagnostics, Inc.
  • Products
    • Infectious Diseases
      • DPP® HIV-Syphilis
      • DPP® HIV 1/2 Assay
      • DPP® Syphilis Screen & Confirm
      • HIV 1/2 STAT PAK® Assay
      • SURE CHECK® HIV 1/2 Assay
      • SURE CHECK® HIV Self-Test
      • STAT-VIEW® HIV 1/2 Assay
    • Tropical & Fever Diseases
      • Chagas STAT PAK® Assay
      • DPP® Zika IgM/IgG System
      • DPP® Zika IgM System
      • DPP® Ebola Antigen System
      • DPP® ZCD IgM/IgG System
    • Respiratory Diseases
      • Status™ COVID-19/FLU
      • DPP® SARS-CoV-2 IgM/IgG
      • DPP® SARS-CoV-2 Antigen
      • SCoV-2 Detect™
      • SCoV-2 Ag Detect™ Rapid Self-Test
    • Handheld Analyzers
      • DPP® Micro Reader
      • DPP® Micro Reader II
    • Veterinary Products
      • DPP® VetTB Assay for Elephants
      • DPP® VetTB Assay for Cervids
  • Innovation
    • Technology
    • Patents
    • Publications
  • Investors
    • Stock Information
    • Press Releases
    • SEC Filings
    • Quarterly Results
    • Financial Reports
    • Analyst Coverage
    • Corporate Governance
    • Events and Presentations
    • E-Mail Alerts
  • Newsroom
  • About
    • Our Team
  • Careers
  • Contact Us
  • Products
    • Infectious Diseases
      • DPP® HIV-Syphilis
      • DPP® HIV 1/2 Assay
      • DPP® Syphilis Screen & Confirm
      • HIV 1/2 STAT PAK® Assay
      • SURE CHECK® HIV 1/2 Assay
      • SURE CHECK® HIV Self-Test
      • STAT-VIEW® HIV 1/2 Assay
    • Tropical & Fever Diseases
      • Chagas STAT PAK® Assay
      • DPP® Zika IgM/IgG System
      • DPP® Zika IgM System
      • DPP® Ebola Antigen System
      • DPP® ZCD IgM/IgG System
    • Respiratory Diseases
      • Status™ COVID-19/FLU
      • DPP® SARS-CoV-2 IgM/IgG
      • DPP® SARS-CoV-2 Antigen
      • SCoV-2 Detect™
      • SCoV-2 Ag Detect™ Rapid Self-Test
    • Handheld Analyzers
      • DPP® Micro Reader
      • DPP® Micro Reader II
    • Veterinary Products
      • DPP® VetTB Assay for Elephants
      • DPP® VetTB Assay for Cervids
  • Innovation
    • Technology
    • Patents
    • Publications
  • Investors
    • Stock Information
    • Press Releases
    • SEC Filings
    • Quarterly Results
    • Financial Reports
    • Analyst Coverage
    • Corporate Governance
    • Events and Presentations
    • E-Mail Alerts
  • Newsroom
  • About
    • Our Team
  • Careers
  • Contact Us
All Posts By

John Finnegan

Recent Posts

  • Chembio Diagnostics Announces Agreement for Reszon Diagnostics International to Manufacture Chembio’s HIV 1/2 STAT-PAK Assay at Chembio Diagnostics Malaysia Facility
  • Chembio Announces EUA Submission for DPP Respiratory Antigen Panel: Test Provides Simultaneous Detection of Flu A, Flu B, and SARS-CoV-2
  • Chembio Launches Commercial Distribution of Third-Party COVID-19 Antigen Assay
  • Preparing for the 2021-2022 Flu Season: What to Expect, and How to Plan Webinar
  • Watch the recorded Webinar, Fighting the Syphilis & HIV Epidemics: Voices from the Field

Recent Comments

    Chembio Logo White

    Visit Our Other SItes

    Chembio Germany

    Chembio Brazil

    Company

    Chembio Diagnostic Systems, Inc.
    555 Wireless Blvd.
    Hauppauge, NY 11788
    +1-631-924-1135

    SDS Documents

    Stay Connected

    Join Mailing List

    © 2022 Chembio Diagnostics, Inc.. Privacy Policy | Terms & Conditions

    Subscribe to the Chembio Mailing List